---
figid: PMC6199328__41467_2018_6810_Fig8_HTML
figtitle: TEdeff-induced immunotherapy resistance
organisms:
- NA
pmcid: PMC6199328
filename: 41467_2018_6810_Fig8_HTML.jpg
figlink: /pmc/articles/PMC6199328/figure/Fig8/
number: F8
caption: A model of TEdeff-induced immunotherapy resistance. Intact transcriptional
  fidelity is essential for the baseline and cytokine (e.g. IFN)-inducible expression
  of the inflammatory response pathways that prime the tumor cell for cytolytic cell
  attack (left). However, in TEdeff cells, transcription elongation defects lead to
  the expression of spurious transcripts and poor nuclear export of the inflammatory
  response pathway genes. This, in turn, severely reduces the sensitivity of the tumor
  cell to the cytolytic T and NK cell-mediated anti-tumor mechanisms (right)
papertitle: Defective transcription elongation in a subset of cancers confers immunotherapy
  resistance.
reftext: Vishnu Modur, et al. Nat Commun. 2018;9:4410.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8499379
figid_alias: PMC6199328__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6199328__F8
ndex: 660926d8-dea4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6199328__41467_2018_6810_Fig8_HTML.html
  '@type': Dataset
  description: A model of TEdeff-induced immunotherapy resistance. Intact transcriptional
    fidelity is essential for the baseline and cytokine (e.g. IFN)-inducible expression
    of the inflammatory response pathways that prime the tumor cell for cytolytic
    cell attack (left). However, in TEdeff cells, transcription elongation defects
    lead to the expression of spurious transcripts and poor nuclear export of the
    inflammatory response pathway genes. This, in turn, severely reduces the sensitivity
    of the tumor cell to the cytolytic T and NK cell-mediated anti-tumor mechanisms
    (right)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FASLG
  - FAS
  - FASN
  - IFNGR1
  - DAXX
  - FADD
  - JAK1
  - JAK2
  - MAP3K5
  - AGFG1
  - RIPK1
  - DCAF1
  - RPAIN
  - CASP8
  - STAT1
  - STAT5A
  - STAT5B
  - STAT3
  - MAPK8
  - MAPK9
  - MAPK10
  - ERVW-4
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - CpG
---
